Moderna Inc said on Monday it has signed a new agreement with Switzerland for the supply of another seven million doses of its COVID-19 booster vaccine for delivery in 2023.
The agreement also includes an option of seven million doses for delivery in 2023 and 2024, the U.S. biotechnology company said in a statement.
These doses are in addition to the seven million doses of booster vaccine that Switzerland previously secured.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments